Norovirus Infections

• CLINICAL_TRIALS trial_result · 2026-04-15
  Clinical Trial Update: A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants [Phase 1]

  Vaxart completed a Phase 1 study evaluating the safety and immunogenicity of its oral bivalent GI.1/GII.4 norovirus vaccine in healthy lacta…

• CLINICAL_TRIALS research · 2025-04-29
  Clinical Trial Update: A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old [Phase 1]

  This Phase 1 clinical trial evaluates an oral norovirus G1.1/G2.4 vaccine in healthy adults aged 18-80, sponsored by Vaxart.

• CLINICAL_TRIALS trial_result · 2022-10-28
  Clinical Trial Update: Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha) [Phase 2]

  Phase 2 clinical trial evaluating a recombinant norovirus bivalent vaccine (GI.1/GII.4) produced in Hansenula polymorpha for Norovirus infec…